secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001023024-25-000056
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI shareholders approve doubling authorized common shares to 66M and equity plan amendments
--------------------------------------------------------------------------------

- Stockholders approved Certificate of Amendment raising authorized common shares from 33,333,334 to 66,000,000; effective May 22, 2025.
- Amended 2022 Stock Incentive Plan approved (15,056,885 for, 1,202,893 against, 10,460 abstain).
- Amended 2016 Employee Stock Purchase Plan approved (16,173,976 for, 89,098 against, 7,164 abstain).
- Eight director nominees elected; EisnerAmper LLP ratified as auditor; say-on-pay advisory approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302425000056/0001023024-25-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302425000056/ani-20250522.htm
  HTML page:      https://secwatch.observer/filing/0001023024-25-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer